Patents by Inventor Acceleron Pharma, Inc.

Acceleron Pharma, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CERBERUS/COCO DERIVATIVES AND USES THEREOF
    Publication number: 20130209462
    Abstract: The invention relates to Cerberus/Dan/Gremlin polypeptides or variants thereof for use in treating a variety of disorders associated with myostatin, nodal and GDF-11. Preferred polypeptides are Coco or Cerberus derivatives.
    Type: Application
    Filed: February 22, 2013
    Publication date: August 15, 2013
    Applicant: ACCELERON PHARMA, INC.
    Inventor: Acceleron Pharma, Inc.
  • ACTIVIN-ACTRIIA ANTAGONISTS FOR INHIBITING GERM CELL MATURATION
    Publication number: 20130195862
    Abstract: In certain aspects, the present invention provides compositions and methods for decreasing FSH levels in a patient. The patient may, for example, be diagnosed with an FSH-related disorder or desire to delay or inhibit germ cell maturation.
    Type: Application
    Filed: January 30, 2013
    Publication date: August 1, 2013
    Applicant: ACCELERON PHARMA, INC.
    Inventor: Acceleron Pharma, Inc.
  • ACTRIIB BINDING AGENTS AND USES THEREOF
    Publication number: 20130189269
    Abstract: The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
    Type: Application
    Filed: March 14, 2013
    Publication date: July 25, 2013
    Applicant: ACCELERON PHARMA, INC.
    Inventor: ACCELERON PHARMA, INC.
  • VARIANTS DERIVED FROM ACTRIIB AND USES THEREFOR
    Publication number: 20130184210
    Abstract: In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, and/or neuronal tissue. The present invention also provides methods of screening compounds that modulate activity of an ActRIIB protein and/or an ActRIIB ligand. The compositions and methods provided herein are useful in treating diseases associated with abnormal activity of an ActRIIB protein and/or an ActRIIB ligand.
    Type: Application
    Filed: December 28, 2012
    Publication date: July 18, 2013
    Applicant: ACCELERON PHARMA, INC.
    Inventor: Acceleron Pharma, Inc.
  • Truncated ActRIIb-Fc Fusion Protein
    Publication number: 20130177559
    Abstract: In certain aspects, the present invention provides compositions and methods for modulating (promoting or inhibiting) growth of a tissue, such as bone, cartilage, muscle, fat, brown fat and/or neuronal tissue and for treating metabolic disorders such as diabetes and obesity, as well as disorders associated with any of the foregoing tissue.
    Type: Application
    Filed: October 22, 2012
    Publication date: July 11, 2013
    Applicant: ACCELERON PHARMA, INC.
    Inventor: Acceleron Pharma, Inc.
  • BMP-ALK3 ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH
    Publication number: 20130101603
    Abstract: In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density and strength. In certain embodiments, the present invention provides ALK3 polypeptides, including ALK3-Fc fusion proteins.
    Type: Application
    Filed: December 21, 2012
    Publication date: April 25, 2013
    Applicant: ACCELERON PHARMA, INC.
    Inventor: Acceleron Pharma, Inc.